Although cytology-based cervical cancer prevention programs have reduced the incidence
of cervical cancer in many industrialized countries, the limited sensitivity of cervical cytology …

Cervical cancer screening has undergone a transformation in recent decades. Historically,
programs were based on cervical cytology (ie,“Pap smear”), which had to be repeated often …

The Pap test is the foundation of cervical cancer screening in North America and most
industrialized countries. It has been widely used in the United States since the 1950s. But …

Background This special section of Preventive Medicine is devoted to cervical cancer
screening. It covers why and how testing for human papillomavirus (HPV) is replacing …

Despite its history of success in cancer screening, Pap cytology has important limitations,
particularly its high false-negative rate, which carries important public health implications …

Abstract In the United States, 12,000 women are diagnosed with cervical cancer each year,
even though the screening for this disease is safe and effective. There are 3 types of …

Population screening for cervical cancer resulted in significant reduction in the morbidity and
mortality from cervical cancer. An increased understanding of the relationship of HPV …

Cytology-based cervical screening had unequivocal success in reducing the incidence and
mortality of cervical cancer in the last century. The recognition of the role of human …

Persistent high-risk human papillomavirus (HPV) infection is a necessary precursor for the
development of cervical cancer. Recent data demonstrating the sensitivity of HPV testing …

Cervical cancer screening involves a complex process of cytology, human papillomavirus
(HPV) testing, colposcopy, and a multitude of algorithms for the identification of preinvasive …